Free Trial

R1 RCM (RCM) Competitors

$12.75
+0.27 (+2.16%)
(As of 05/28/2024 ET)

RCM vs. TMX, MANT, PINC, FC, LH, DGX, DVA, CHE, CRVL, and AMED

Should you be buying R1 RCM stock or one of its competitors? The main competitors of R1 RCM include Terminix Global (TMX), ManTech International (MANT), Premier (PINC), Franklin Covey (FC), Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), and Amedisys (AMED).

R1 RCM vs.

Terminix Global (NYSE:TMX) and R1 RCM (NASDAQ:RCM) are both mid-cap industrial products companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, community ranking, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation.

Terminix Global has higher earnings, but lower revenue than R1 RCM. R1 RCM is trading at a lower price-to-earnings ratio than Terminix Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Terminix Global$2.05B2.25$125M$0.5371.45
R1 RCM$2.25B2.38$3.30M-$0.08-159.38

92.2% of Terminix Global shares are held by institutional investors. Comparatively, 61.1% of R1 RCM shares are held by institutional investors. 2.3% of Terminix Global shares are held by insiders. Comparatively, 36.8% of R1 RCM shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

R1 RCM has a consensus price target of $16.31, suggesting a potential upside of 27.90%. Given Terminix Global's higher possible upside, analysts plainly believe R1 RCM is more favorable than Terminix Global.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Terminix Global
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
R1 RCM
0 Sell rating(s)
5 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.62

Terminix Global has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500. Comparatively, R1 RCM has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500.

In the previous week, R1 RCM had 5 more articles in the media than Terminix Global. MarketBeat recorded 5 mentions for R1 RCM and 0 mentions for Terminix Global. Terminix Global's average media sentiment score of 1.28 beat R1 RCM's score of 0.00 indicating that R1 RCM is being referred to more favorably in the news media.

Company Overall Sentiment
Terminix Global Neutral
R1 RCM Positive

R1 RCM received 216 more outperform votes than Terminix Global when rated by MarketBeat users. However, 61.32% of users gave Terminix Global an outperform vote while only 57.94% of users gave R1 RCM an outperform vote.

CompanyUnderperformOutperform
Terminix GlobalOutperform Votes
65
61.32%
Underperform Votes
41
38.68%
R1 RCMOutperform Votes
281
57.94%
Underperform Votes
204
42.06%

Terminix Global has a net margin of 3.15% compared to Terminix Global's net margin of -1.39%. R1 RCM's return on equity of 4.95% beat Terminix Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Terminix Global3.15% 4.95% 2.67%
R1 RCM -1.39%-1.16%-0.62%

Summary

Terminix Global and R1 RCM tied by winning 8 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RCM vs. The Competition

MetricR1 RCMManagement services IndustryBusiness SectorNASDAQ Exchange
Market Cap$5.37B$5.53B$6.56B$8.09B
Dividend YieldN/A3.53%3.01%3.96%
P/E Ratio-159.3817.1521.3918.43
Price / Sales2.3846.78854.7472.31
Price / Cash18.2115.5924.9328.77
Price / Book1.9410.734.584.39
Net Income$3.30M$225.26M$117.64M$213.55M
7 Day Performance3.83%-0.17%-0.48%-0.80%
1 Month Performance7.14%-3.05%8.57%3.42%
1 Year Performance-20.61%-9.24%7.10%7.53%

R1 RCM Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TMX
Terminix Global
0 of 5 stars
$37.87
flat
N/AN/A$4.61B$2.05B71.4511,700
MANT
ManTech International
0 of 5 stars
$95.98
flat
N/A+0.0%$3.93B$2.55B32.329,800
PINC
Premier
3.1631 of 5 stars
$19.04
+0.3%
$23.50
+23.4%
-26.1%$2.00B$1.34B29.752,800Analyst Forecast
FC
Franklin Covey
3.7387 of 5 stars
$37.61
+0.4%
$66.33
+76.4%
-0.7%$499.09M$280.52M30.581,160Analyst Forecast
Short Interest ↓
News Coverage
LH
Laboratory Co. of America
4.7377 of 5 stars
$197.32
-1.2%
$243.14
+23.2%
-9.0%$16.63B$12.16B39.7067,000Analyst Upgrade
Positive News
DGX
Quest Diagnostics
4.8737 of 5 stars
$139.05
-1.6%
$146.17
+5.1%
+3.8%$15.45B$9.25B18.7148,000
DVA
DaVita
3.0463 of 5 stars
$143.32
+3.5%
$144.67
+0.9%
+52.4%$12.57B$12.14B16.2970,000Positive News
CHE
Chemed
4.7739 of 5 stars
$546.50
-1.6%
$673.50
+23.2%
+0.3%$8.27B$2.26B29.4115,087
CRVL
CorVel
0 of 5 stars
$266.50
-3.7%
N/A+29.7%$4.56B$795.31M60.574,444Analyst Downgrade
Short Interest ↑
News Coverage
AMED
Amedisys
2.9414 of 5 stars
$96.17
-0.1%
$100.80
+4.8%
+23.7%$3.14B$2.25B-150.2619,000Positive News

Related Companies and Tools

This page (NASDAQ:RCM) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners